Evidence map›Paper›PMID 40326707›Full record

ArticleThe British journal of radiology2025

FLASH-induced DNA damage reduction measured in vitro correlates with effective oxygen depletion determined in silico: further support for oxygen depletion contributing to FLASH's reduced damage burden in vitro.

Bethany Rothwell, Christian R Cooper, Donald J L Jones, Michael J Merchant, Norman F Kirkby, Karen J Kirkby, Kristoffer Petersson, Jan Schuemann, George D D Jones

Abstract read
In one paragraph

Article in The British journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bethany RothwellPhysics Division, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA 02114, United States.ORCID 0000-0002-3323-671X
Christian R CooperOxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.
Donald J L JonesLeicester Cancer Research Centre, Department of Genetics, Genomics & Cancer Sciences, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Michael J MerchantDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, United Kingdom.
Norman F KirkbyDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, United Kingdom.
Karen J KirkbyDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, United Kingdom.
Kristoffer PeterssonOxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.
Jan SchuemannPhysics Division, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA 02114, United States.
George D D JonesLeicester Cancer Research Centre, Department of Genetics, Genomics & Cancer Sciences, University of Leicester, Leicester, LE1 7RH, United Kingdom.ORCID 0000-0002-9543-2206

Funding

Translational Studies in FLASH Particle RadiotherapyP01CA257904 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Mary E. Putt · 2022 to 2026
$14.2M
Using experimentally-guided multi-scale modeling to determining the mechanism of FLASH tissue sparingR01CA266419 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2022 to 2025
$3.3M
Dose-Rate Variations for Patient Treatments in Flash and conventional radiation therapyR21CA252562 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2021 to 2022
$416k
Association for Radiation ResearchCancer Research UK RadNet C6078/A28736DHHS 1P01CA257904Leicester Cancer Research CentreMedical Research Council UK MR/X006611/1NCI NIH HHS P01 CA257904NCI NIH HHS R01 CA266419NCI NIH HHS #R21 CA252562NCI NIH HHS R21 CA252562NIHUniversity of Leicester
6 · The paper itself

Abstract

objectivesFLASH irradiation demonstrates notable normal-tissue protective effects, including reduced damage in vitro. Radiochemical mechanisms proposed include radical-radical recombination and transient oxygen depletion (TOD), but the relative contributions remain unclear. This study compares FLASH-mediated DNA damage reduction in vitro with oxygen depletion for FLASH radiotherapy modelled in silico, to (i) investigate the contribution of TOD towards the reduced damage burden in vitro, and (ii) evaluate its contribution to the broader FLASH effect in vivo.

methodsAn in silico model was used to identify and compare the parameter space for FLASH-induced oxygen depletion in an in-vitro setup with experimental DNA damage reduction data, previously determined using the alkaline comet assay ex vivo.

resultsCorrelation analysis revealed a strong relationship between model-predicted oxygen depletion and experimentally-observed DNA damage reduction (Spearman's = 0.87, P = 2 × 10-6; Pearson's = 0.85, P = 4 × 10-6).

conclusionsFindings support a significant role for TOD in the FLASH-induced reduction in damage in vitro at low oxygen tensions. However, parameter spaces identified, for both oxygen depletion in silico and DNA damage reduction in vitro, suggest that TOD may only partially contribute to the wider-ranging FLASH sparing effects in vivo. Further work is required to clarify this. ADVANCES IN KNOWLEDGE: Findings support TOD as a key mechanism for the reduced damage burden of FLASH in vitro. However, further work is required to demarcate the sparing effects of FLASH in vivo.

Indexed as

DNA DamageOxygenComet AssayComputer SimulationHumansOxygendamage burdenFLASH radiotherapytransient oxygen depletion

Identifiers

PMID40326707
PMCPMC12202011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.